from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3696c/glpK

LFCtreatmentdescriptionclass of inhibitor

-0.130

Amikacinug/mL Amikacintranslation

-1.108

Cap5-10ug/mL Capreomycintranslation

-0.989

Rox10-50 ug/mL Roxithromycintranslation

0.697

SM2-5 ug/mL Streptomycintranslation

1.448

Tet5-10 ug/mL Tetracyclinetranslation

-0.081

Rif0.2-5ug/mL Rifampicintranscription

-0.343

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.883

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.905

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.437

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.396

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.083

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.356

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.241

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.269

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.630

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.159

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.156

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.704

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.073

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.751

KCN5-20 ug/mL Potassium cyaniderespiration

-0.037

NaN30.2-2 mM Sodium aziderespiration

0.047

Nigericin50 uM Nigericinrespiration

-0.399

TRC10-150 ug/mL Triclosanrespiration

-1.139

TRZ10-25 ug/mL Thioridazinerespiration

-0.875

Valinomycin0.5-10 uM Valinomycinrespiration

0.920

ZnSO42 mM ZnSO4respiration

-0.652

menadione6-10 ug/mL Menadionerespiration

-0.520

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.465

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.352

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.060

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.130

NRP_1Non-replicating persistence stage 1dosRassociated

0.430

Amp0.2mg/mL AmpicillincellWall

0.575

Cephalexin20-100 ug/mL CephalexincellWall

0.474

Cerulenin0.32-5 ug/mL CerulenincellWall

0.467

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.213

EMB10-20 ug/mL EthambutolcellWall

1.129

Eta12-40 ug/mL EthionamidecellWall

0.259

INH0.2-0.4 ug/mL IsoniazidcellWall

0.003

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.072

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.176

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.446

BZA0.12 mg/mL BenzamidearomaticAmides

0.161

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.250

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.133

H2O24 mM hydrogen peroxideDNAdamaging

-0.199

Levo10 ug/mL LevofloxacinDNAdamaging

0.181

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.875

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.054

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.247

UVUV-irradiationDNAdamaging

-0.448

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.225

Antimycin12.5-50 ug/mL Antimycin A?

0.335

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.294

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.177

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.837

PA8240.2-2 ug/mL PA-824?

-0.246

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.486

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.236

Verapamil50 uM Verapamil?

0.618

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.339

methoxatin10-20 ug/mL Methoxatin?